Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge

The IPO market has experienced a resurgence, thanks in part to the success of CoreWeave. Read on to learn about three other new issues making headlines in 2025.

These 3 Dividend Stocks Combine Strong Yields With Upside

These 3 Dividend Stocks Combine Strong Yields With Upside

These three high-yield dividend stocks are well-positioned to deliver a strong return, making them attractive to both income and growth-oriented investors

Dan Ives Just Unveiled His AI ETF—Does It Live Up to the Hype?

Dan Ives Just Unveiled His AI ETF—Does It Live Up to the Hype?

The head-turning Wall Street analyst Dan Ives has launched his AI Revolution ETF. Take a deep dive into what his intriguing new fund can offer investors.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Congress’s May Stock Trades: What They Know That You Don’t

Congress bought and sold stocks in May, raising no red flags but highlighting opportunities in the tech sector, including critical semiconductor companies.

McDonald’s Is Down, But Long-Term Investors Can Still Take a Bite

Analysts are downgrading McDonald's and the stock may have further to fall, but as a long-term opportunity, it may be getting to a point of offering real value

Rivian vs. Lucid: Who’s Best Positioned to Steal Tesla’s Thunder?

Rivian and Lucid have exciting developments including new models and partnerships, but will that be enough to take on Tesla?

Russell Rebalance: 3 Stocks Ready to Move Higher

The Russell reconstitution is underway; here are three stocks that are garnering interest as stocks that could move up to the Russell 1000

inkl

Read news from The Economist, FT, and more,
with one subscription

Robinhood Director Sells Millions, But HOOD Stock Eyes Gains

Robinhood Director Sells Millions, But HOOD Stock Eyes Gains

A Robinhood director sold over $30 million worth of stock, which might usually be a worry to shareholders, though this time it shouldn't be.

Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill

Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill

Coinbase just got a big win as lawmakers embraced stablecoins. COIN may have serious untapped potential as some see the stablecoin market growing exponentially.

Super Micro Computer Stock's Rally Backed by Strong Financials

Super Micro Computer Stock's Rally Backed by Strong Financials

Super Micro Computer stock has a new reason to keep its momentum going for the coming months, rooted in fundamentals and financial growth.

Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer

Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer

Home Depot's sales offer a clear, real-time indicator of U.S. consumer health, reflecting spending trends from homeowners and professional contractors.

Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why

Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why

Wall Street analysts see a new reason to boost Taiwan Semiconductor stock today, leaning on the company's fundamental positioning.

3 Tech Stocks With High and Rising Institutional Interest

3 Tech Stocks With High and Rising Institutional Interest

Insider activity surged for these tech stocks in 2025 and is lifting their stock prices; analysts forecast higher highs, which may be reached soon.

Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?

Get all your
news in one place.

100’s of premium titles.
One news app.

Why Meta Stock Investors Should Watch Its Bold Bet on Scale AI

Meta just dropped $14B on Scale AI to shake the competition and pursue AI profits. Much of its future now rests in the hands of a 28-year-old startup founder.

3 Growth Stocks Too Small for Institutions to Buy

These three growth stocks are seemingly out of the reach of most institutional players, leaving retail investors with a great advantage.

Alibaba Call Options Surge, New Hopes of a Trade Deal?

An unusual amount of call option buying took place recently for shares of Alibaba as investors bet that the company will rally soon.

Cantor Boosts Rocket Lab Target to Street-High $35

Cantor Fitzgerald raised its Rocket Lab price target to a street-high $35, citing strong growth potential and impressive strategic expansion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Why Amazon Could Be About To Breakout To $250

Amazon is trading right around a key resistance zone, but bullish analysts and strong technicals suggest a potential breakout to $250 is on the cards.

Chime’s Smart IPO: Half the Valuation, Double the Strength

Chime Financial's impressive market debut highlights a disciplined strategy focused on profitability, establishing a strong foundation for sustainable growth.

Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks

Quantum Computing Inc.'s newly opened chip foundry provides a tangible path to revenue by serving the massive photonics market, an industrial advantage.

3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated

Archer Aviation fundamentally de-risked its future with a capital raise, a global certification alliance, and a new international commercial partnership.

Top 3 Silver Picks to Watch as Bull Market Gains Steam

Silver has broken above $37 per ounce and may outperform gold in 2025; many investors are looking for stocks that are alternatives to owning physical silver

Tesla Bulls and Bears Collide: What Investors Should Know

Tesla faces some near-term headwinds, but the widening gap between the bears and the bulls is creating an opportunity for believers.

Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences

After a second patient passed away, Sarepta Therapeutics crashed. Solid Biosciences rose over 10% in response. Wall Street sees big upside in both names.

1 … 103 104 105 106

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

348,579 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play